{"database":"Pride","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Raw":["ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample71.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample38_2.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample41.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample23.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample37.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample24.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample10.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample49.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample40.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample11.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample19.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample54.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample06.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample67.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample53.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample07.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample36.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample66.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample73.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample30.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample39_2.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample03.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample20.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample22.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample77.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample48.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample34.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample25.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample39.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample08.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample65.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample05.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample68.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample51.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample56.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample13.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample17.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample42.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample75.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample76.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample62.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample33.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample15.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample01.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample03.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample57.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample46.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample50.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample14.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample44.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample62.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample46.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample28.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample59.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample44.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample31.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample01.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample58.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample32.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample28.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample34.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample13.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample74.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample70.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample77.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample60.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample16.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample42.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample56.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample52.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample48.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample08.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample05.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample38.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample64.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample21.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample69.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample18.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample26.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample72.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample24.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample36.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample49.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample10.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample37.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample66.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample07.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample53.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample23.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample41.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample71.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample06.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample67.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample11.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample19.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample54.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample29_2.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample40.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample70.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample40_2.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample21.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample09.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample64.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample12.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample52.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample69.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample26.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample04.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample47.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample43.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample18.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample55.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample60.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample35.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample38.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample78.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample72.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample36_2.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample63.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample50.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample20.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample02.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample59.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample16.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample27.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample31.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample63.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample29.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample61.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample74.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample76.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample14.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample32.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample27.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample45.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample75.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample02.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample29.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample58.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample15.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample37_2.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample45.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample61.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample39.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample01_190727062453.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample65.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample22.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample57.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample17.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample73.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample33.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample25.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample68.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample30.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample09.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample78.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample35.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample04.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample55.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample43.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190711_Conklin_Cell_DIA_Sample51.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample47.raw","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/QEHF_20190725_Conklin_ECM_DIA_Sample12.raw"],"Other":["ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/20240329_180335_20190711_Conklin_Cell_base.sne","ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD051458/20240330_101437_20190725_Conklin_ECM_base.sne"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"labhead_mail":["kirk.hansen@cuanschutz.edu"],"submitter":["Kirk  Hansen"],"technology_type":["Mass Spectrometry","Bottom-up proteomics","Data-independent acquisition"],"disease":["Breast Cancer"],"software":[""],"submitter_keywords":["Tumor","Breast cancer","Extracellular matirx","Bmi"],"full_dataset_link":["https://www.ebi.ac.uk/pride/archive/projects/PXD051458"],"tissue":["Mammary Gland"],"sample_protocol":["Two step tissue fractionation 1. Cell fraction extracted with high salt CHAPS buffer 2. chemical digestion with hydroxylamine for a cell and ECM fraction respectively. Data aquired on a QE HF instrument."],"repository":["Pride"],"quantification_method":[""],"modification":[""],"data_protocol":["Spectronaut (version 18.6) - DirectDIA analysis.    ├─ Pulsar Search\\Identification    │  ├─ PSM FDR: 0.01    │  ├─ Peptide FDR: 0.01    │  ├─ Protein Group FDR: 0.01    │  ├─ directDIA Workflow: directDIA+ (Deep)    │  └─ PTM Localization Filter: False    ├─ Pulsar Search\\Modifications    │  ├─ Max Variable Modifications: 9    │  └─ Select Modifications:     │     ├─ Fixed Modifications:: Carbamidomethyl (C)    │     └─ Variable Modifications: : Gln->pyro-Glu, Oxidation (M), Oxidation (P)"],"omics_type":["Proteomics"],"labhead":["Kirk Hansen"],"instrument_platform":[""],"labhead_affiliation":["University of Colorado, School of Medicine"],"submission_type":["PARTIAL"],"species":["Homo Sapiens (human)"],"submitter_mail":["kirk.hansen@ucdenver.edu"],"publication":["39380725 Bamberg EE, Maslanka M, Vinod-Paul K, Sams S, Pollack E, Conklin M, Kabos P, Hansen KC. Obesity-driven changes in breast tissue exhibit a pro-angiogenic extracellular matrix signature. Matrix Biol Plus. 2024 24:100162 10.1016/j.mbplus.2024.100162"],"submitter_affiliation":["University of Colorado"],"submitter_country":["United States"],"pubmed_abstract":["Obesity has reached epidemic proportions in the United States, emerging as a risk factor for the onset of breast cancer and a harbinger of unfavorable outcomes [1], [2], [3]. Despite limited understanding of the precise mechanisms, both obesity and breast cancer are associated with extracellular matrix (ECM) rewiring [4], [5], [6]. Utilizing total breast tissue proteomics, we analyzed normal-weight (18.5 to < 25 kg/m<sup>2</sup>), overweight (25 to < 30 kg/m<sup>2</sup>), and obese (≥30 kg/m<sup>2</sup>) individuals to identify potential ECM modifying proteins for cancer development and acceleration. Obese individuals exhibited substantial ECM alterations, marked by increased basement membrane deposition, angiogenic signatures, and ECM-modifying proteins. Notably, the collagen IV crosslinking enzyme peroxidasin (PXDN) emerged as a potential mediator of the ECM changes in individuals with an elevated body mass index (BMI), strongly correlating with angiogenic and basement membrane signatures. Furthermore, glycan-binding proteins galectin-1 (LGALS1) and galectin-3 (LGALS3), which play crucial roles in matrix interactions and angiogenesis, also strongly correlate with ECM modifications. In breast cancer, elevated PXDN, LGALS1, and LGALS3 correlate with reduced relapse-free and distant-metastatic-free survival. These proteins were significantly associated with mesenchymal stromal cell markers, indicating adipocytes and fibroblasts may be the primary contributors of the obesity-related ECM changes. Our findings unveil a pro-angiogenic ECM signature in obese breast tissue, offering potential targets to inhibit breast cancer development and progression."],"pubmed_title":["Obesity-driven changes in breast tissue exhibit a pro-angiogenic extracellular matrix signature."],"pubmed_authors":["Bamberg Ellen E EE, Maslanka Mark M, Vinod-Paul Kiran K, Sams Sharon S, Pollack Erica E, Conklin Matthew M, Kabos Peter P, Hansen Kirk C KC"],"pubmed_abstract_synonyms":["Lect14, lamina densa, Collagens, Macrophage-2 Antigen, FON1, basement membrane of connective tissue, Stem Cells, Stromal Cells, Lactiferous gland, Mesenchymal Stromal Cells, growth and development, Risk Factor Score, Tumor, FLORAL ORGAN NUMBER 1, CG17228, 1135/09, 1135/07, unspecified, Risk Factors, Body Mass, IgE Binding, Galactoside-Binding Lectin 1, Antigen, symptoms, 0451/09, cancer of the breast, Extracellular Matrices, Correlates, Multipotent Mesenchymal Stromal Cells, BC, average, 0244/09, L-14.5, Tissue, Bdr, DROPROSA, Age of onset, Bone Marrow Stromal Stem Cells, L 29 Lectin, SNAP-25, Lamina, Social, 671/2, GPIa*, Health Correlates, cancer of breast, Collagen Fleece, Glycan, Role Concepts, marrow stromal cells, Breast Malignant Neoplasms, Lamina Densa, Tumors, screening, Galectin-1, Index, Galectin-3, obese, Mesenchymal Progenitor Cells, Glykane, Mesenchymal Stromal Cell, Benign, Role Concept, Playthings and Play, Recrudescence, Lobe of mammary gland, Quetelet's Index, 1316/02, Obesity [Ambiguous], Role, OBESITY, GENA70, BcDNA:HL08040, simple tissue, PXDN, Carcinomas, MAC2, Lucida, Adipose-Derived Mesenchymal Stem Cells, mesenchymal stromal cells, Social Risk Factors, death rate, Adipose Tissue Derived Mesenchymal Stromal Cells, Basal, Mac-2 Antigen, 1167/13, signs, Adiposity, Benign Neoplasms, VPO, OBESITY NOS, \"mammary neoplasm\" RELATED [], Malignant Neoplasms, Adipose-Derived Mesenchymal Stromal Cells, Adipose Derived, breast cancer, Epsilon-Binding Protein, Fat Cell, Breast Tumors, Cells, Breast Malignant Tumors, Collagen Felt, Adipose Tissue Derived Mesenchymal Stem Cell, l(1)16Fg, 0989/01, cancer, Binding Proteins, Fibroblast, pds, FLORAL DEFECTIVE 10, Lectin, Mesenchymal Stem Cell, Carrier Protein, Peptidomics, Biocatalysts, Neoplasms, L-14 Lectin, obesity disease, Mammary Cancers, Densas, Angiogeneses, Wharton's Jelly Cells, SUPERMAN, 0763/13, Human, stem cells, Breast Malignant Tumor, DmelCG17228, Breast Tumor, Dermodress, Stromal Cell, Collastat, Gene Products, breast tumor, Prosp, Wharton's Jelly Cell, mesenchymal stromal cell, Risk Factor, Polysaccharide, Toy, F15E12_6, Playthings, Mammary Neoplasm, Recrudescences, Mammary Carcinoma, Avitene, alpha Collagen, Population at Risk, BMI, l(3)rH013, Neoplasias, IgEBP, Enzyme, Prodos, Puppets, Malignant Tumor of Breast, Extracellular, blood vessel formation from pre-existing blood vessels, Lipocyte, Bone Marrow Mesenchymal Stem Cell, Puppet, L1-Lac, Cancer, 0671/02, l(3)j12C8, Breast Carcinoma, Human Mammary Neoplasm, Breast Carcinomas, findings, Malignant Neoplasm, membrana basalis, Progenitor Cells, Proteins, MG50, Factor, Synaptosomal-associated 25 kDa protein, \"breast tumor\" EXACT [NCI2004_11_17:C2910], Cell, EMILIN4, Concept, L-29 Lectin, l(3)rL433, MT, l(3)rI160, 0441/16, Neoplasm, Collagen Hemostat, Human Mammary Carcinoma, basement lamina, Obesity (disorder), MET, ATCMPG1, ATCMPG2, polisacaridos, Bone Marrow Stromal Cell, primary cancer, United States of America, underdeveloped, Obesity NOS, Lobe of breast, postnatal growth, ob, OB, Cancers, Understanding, malignant tumor, MSC cell, l(3)rK204, Gene Proteins, Quetelets Index, Adipose Tissue-Derived Mesenchymal Stem Cells, Multipotent, Cancer of Breast, Neoplasia, breast, l(3)rK137, malignant tumor of the breast, Breasts, postnatal development., postnatal development, LGALS3, LGALS2, mammary neoplasm, LGALS1, Human Mammary Neoplasms, Glykan, Multipotent Mesenchymal Stromal Cell, glandula mammaria, Adiposis, Galaptin, CBP30, gal-3, Obese, Readability, polisacarido, Reticularis, relapse, \"neoplasm of breast (disorder)\" EXACT [SNOMEDCT_2005_07_31:126926005], Roles, SUP, Concepts, Relapses, Zyderm, mesenchymal precursor cell, CBP35, Transport Proteins, Mammary Neoplasms, malignant neoplasm of breast, Glycans, MUB3_18, Recurrences, Microfibril Collagen Hemostat, Human Mammary Carcinomas, hypoplasia, U.S., Glycane, mesenchymal, Super protein, MUB3.18, l(3)j6E2, CFU-F, sp, Bone Marrow Mesenchymal Stem Cells, 0320/10, DMPROSPER, collagen, PRG2, malignant neoplasm, Quetelet, Whartons Jelly Cells, Accelerations, Lipocytes, Malignancies, basal lamina, Collagen, mammary cancer, L1 Lac Lectin, mamma, Relapse, Carcinoma, Basement, GALBP, \"breast neoplasm\" EXACT [MTH:120], l(3)rO534, PRO, Pro, Macrophage-2, Galbp, Carrier, Adipose Tissue-Derived Mesenchymal Stem Cell, CYS, Fat Cells, PROS-1, PROS-2, weight, colony-forming unit-fibroblast, Stem Cell, pro, Obese (finding), Carbohydrate-Binding Protein 35, Plaything, Score, NOS, Carbohydrate Binding Protein 35, Basement Membranes, Malignant Neoplasm of Breast, Binding Protein, and GLY protein 2, Adipocyte, Lamina Reticularis, Adipose-Derived, and GLY protein 1, IgE, Factors, Risk, Voila, 0664/07, Toys, Gbp, GBP, L1-Lac Lectin, Adipose Tissue Derived Mesenchymal Stem Cells, TAF[[II]], polysaccharides, mesenchymal stem cell, Social Risk, metastatic, Health, Mesenchymal Progenitor Cell, Biocatalyst, Mesenchymal, Adipose Derived Mesenchymal Stromal Cells, Bone Marrow Stromal Cells, Fat, mammary region, primary breast cancer, D2S448, Multipotent Bone Marrow Stromal Cells, Plays, Mesenchymal Stem Cells, Benign Neoplasm, IgE Binding Protein, Progenitor Cell, AA410090, Matrix, alpha-Collagen, glycans, Gene, Adipose Tissue Derived Mesenchymal Stromal Cell, Matrices, Malignant, L30 Lectin, bone marrow stromal cells, l(3)10419, Obesity, dmTAF8, Microfibril, reduced, HL-VIII, \"mammary tumor\" EXACT [CSP2005:2016-0671], anon-WO0140519.15, F15E12.6, Wharton Jelly Cells, tiny, AGE-R3, Quetelet Index, Adipose Tissue-Derived Mesenchymal Stromal Cells, PROS, Adipose Derived Mesenchymal Stem Cells, Human Mammary, matrisome, 0585/13, Populations at Risk, PXN, Malignancy, Lamina Lucida, Having too much body fat, mammary part of chest, CG7128, Risk Score, mesenchymal progenitor cells, Overweight and obesity, GALIG, L-31, MSC, Cancer of the Breast, Mif1, prod, L-14, time of survival, Mammary, Mammary Cancer, ECM, L14, Social Risk Factor, Play, Mac 2 Antigen, Breast, TAF, 0563/18, mammary tumor, Collagenfleece, Galactoside-Binding, Adipose Derived Mesenchymal Stem Cell, Mac-2, small, basement membrane, Adipose-Derived Mesenchymal Stem Cell, Basement Lamina, Peroxidasins, gal3, D2S448E, Risk Factor Scores, Brustdruese, obesity, GAL1, l(3)rJ806, Pros, Breast Malignant Neoplasm, L-34, development, survival, HL-29, Mammary Carcinomas, L31, Protein, TFIID, Epsilon Binding Protein, obesity disorder, Pangen, Gal-1, Membranes, CBP-30, BMSC, Breast Neoplasm, Transport Protein, CBP-35, other collagen, Multipotent Bone Marrow Stromal Cell, Adipose Tissue-Derived Mesenchymal Stromal Cell, Avicon, FLO10, Age symptoms begin, Membrane, HERP, Risk Scores, galectin-1, Protein Gene Products, GAL3, Basal Lamina, DmelCG7128, SNAP, Breast Cancer, Lectin 1, Macrophage 2 Antigen, MMRN, TAF8, growth, Galactoside Binding Lectin 1"],"name_synonyms":["mamma, Peptidomics., mammary region, primary cancer, Breasts, Malignant Neoplasm, Malignancy, Neoplasms, Lobe of breast, mammary part of chest, Tissue, Benign Neoplasm, Lactiferous gland, Benign Neoplasms, Cancers, Tumor, Brustdruese, Malignant, malignant tumor, glandula mammaria, Malignant Neoplasms, Neoplasias, MT, Benign, malignant neoplasm, Lobe of mammary gland, Neoplasm, simple tissue, Malignancies, Neoplasia, breast, Cancer, Tumors"],"data_synonyms":["SH2-Bb, glutamic acid, DmGluClalpha, SH2 domain-containing protein 1B, posttranslational modification, dmMOF, determination, p150/glued, l(3)S007412, SMC4, unsegmented paraxial mesoderm, Glu, GLU, Irip, l(3)61Ea, Gene, CG9206, protein, Dmel_CG1086, P150, protein-containing complex, somitomeric mesoderm, GCPII, NAALAdase, glc, DmelCG9648, peptide, NAALADase I, Polypeptides, Glt1, FOLH, protein polypeptide chains, DmelCG3025, DmGluT1, 2-Aminoglutaric acid, dSMC4, peptido, polypeptide chain, DmSMC4/gluon, dMOF, p150, Gene Products, establishment and maintenance of position, N-acetylated-alpha-linked acidic dipeptidase I, glu, C530001K22Rik, mKIAA1299, Diethylaminoethyldextran, 3.4.17.21, establishment and maintenance of substrate location, DmGlu, protein aggregate, Work Flow, t1, dGluCl-alpha, SH2-B, Glutamic acid, somitogenic mesoderm, SH2B, posttranslational amino acid modification, MAX, E, PPG, peptides, BcDNA:HL07853, Membrane glutamate carboxypeptidase, DmelCG11397, dMax, DmGLUT1, mGCP, proteins, NAALAD1, posttranslational protein modification, DrosGluCl, Folylpoly-gamma-glutamate carboxypeptidase, 2-(diethylamino)ethyl ether, Dmglut1, set, DrosGluCl-alpha, DmSMC4, max, grupos, CT23049, peptidos, CG7535, Glutaminic acid, GLUCL, DEAE, DrosGluCl-alpha1, establishment and maintenance of substance location, GluCl, DEAE Dextran, BcDNA:LD20207, grupo, unsegmented mesenchyme, protein complex, CG13908, Proteins, CG3025, CG9648, CG1086, DrosGlu-Cl-alpha., SH2-B PH domain-containing signaling mediator 1, Peptide, GCP2, group, GIG27, AI875693, bHLHd7, 0074/12, Dmel_CG13908, Glutamate carboxypeptidase II, bHLHd6, polypeptide, bHLHd9, bHLHd8, single organism localization, Cell growth-inhibiting gene 27 protein, Workflows, p150[Glued], bHLHd5, bHLHd4, DmelCG9206, native protein, natural protein, PSM, Psm, Glutamate, DEAE Sephadex, chemical analysis, Protein, p150[glued], dmax, p150/Glued, glut1, establishment and maintenance of localization, segmental plate, Prostate-specific membrane antigen, presumptive somite mesoderm, GluCla, Mopsm, Sh2bpsm1, Glutaminsaeure, Pulsar, DYNA_DROME, CG11397, DmelCG7535, Pteroylpoly-gamma-glutamate carboxypeptidase, PH and SH2 domain-containing signaling mediator, DL-Glutaminic acid, 2-aminopentanedioic acid, PTM, DmelCG43946, Dm-GluCl, ensemble, FGCP, FCP-D, Rest, single-organism localization, Sephadex, l(2)k08819, Folate hydrolase 1, post-translational amino acid modification, Protein Gene Products, BcDNA.LD20207, Pro-rich, Gene Proteins, GLP-1, MOF, Mof, CG43946, localisation, post-translational modification, AI425885, AA960152, Dextran, PSMA, Peptid, l(3)L1H, Gluon, assay, Polypeptide, anon-WO0118547.156, groupe, Work Flows, P150[Glued], Gruppe, establishment and maintenance of cellular component location, DL-Glutamic acid"],"pubmed_title_synonyms":["l(3)rK137, mammary region, Breasts, obesity disease, Lactiferous gland, Matrix, Matrices, 0763/13, CG17228, glandula mammaria, Adiposis, l(3)10419, 1135/09, Obesity, 1135/07, Obese, dmTAF8, unspecified, DmelCG17228, HL-VIII, 0451/09, anon-WO0140519.15, F15E12.6, Prosp, Extracellular Matrices, PROS, F15E12_6, 0244/09, matrisome, 0585/13, MUB3_18, Having too much body fat, mammary part of chest, Tissue, DROPROSA, CG7128, Overweight and obesity, MUB3.18, l(3)j6E2, l(3)rH013, 671/2, prod, 0320/10, Prodos, DMPROSPER, Extracellular, TAF, 0563/18, 0671/02, mamma, l(3)j12C8, l(3)rO534, PRO, Pro, Brustdruese, CYS, obesity, l(3)rJ806, Pros, l(3)rL433, PROS-1, PROS-2, l(3)rI160, 0441/16, pro, Lobe of mammary gland, 1316/02, Extracellular., Obesity [Ambiguous], Obese (finding), OBESITY, TFIID, BcDNA:HL08040, simple tissue, and GLY protein 2, obesity disorder, Obesity (disorder), MET, ATCMPG1, ATCMPG2, and GLY protein 1, Exhibit, Voila, Obesity NOS, 0664/07, Lobe of breast, 1167/13, Adiposity, OBESITY NOS, TAF[[II]], l(3)rK204, DmelCG7128, l(1)16Fg, TAF8, 0989/01, breast, pds"],"description_synonyms":["mamma, mammary region, Bank, primary cancer, Breasts, Malignant Neoplasm, Malignancy, Tissue Banking, Neoplasms, BMI., Lobe of breast, mammary part of chest, Tissue, Benign Neoplasm, Lactiferous gland, Tissue Bank, Benign Neoplasms, Cancers, Banks, Tumor, Brustdruese, Malignant, malignant tumor, glandula mammaria, sample population, Malignant Neoplasms, Neoplasias, Banking, MT, Benign, malignant neoplasm, Lobe of mammary gland, sample, Quetelet's Index, proteomic analysis, Neoplasm, simple tissue, Malignancies, Neoplasia, breast, Cancer, Tumors"],"sample_synonyms":["Hydroxylamine Hydrochloride, d230, GRP1/cytohesin 1, instrument configuration, dTAFII250, EfW1, Buffer, CG11633, cytohesin/GRP1, dmTAF[[II]]230, hydroxide, halite, 12-trihydroxy-24-oxocholan-24-yl)amino)propyl)-, dmTAF1, Taf230, GRP1, Grp1, ionic compounds, Msal-1, cell fraction, 7, TAF250, hardware., Taf200, dTAF[[II]]250, TFIID TAF250, cel, cell, N, PTPSTEP, Tissue, Salt, l(2)SH2 0323, chlorure de sodium, HardwareType, Msal, Taf1p, sel, Salz, salts, cloruro sodico, dTAF250, salt, Hydroxylammonium Chloride, Neural-specific protein-tyrosine phosphatase, GPIa*, l(2)k08110, sels, ECM, Kochsalz, 12alpha)-3, TAF, 12-trihydroxy-24-oxocholan-24-yl)amino)-, GPH, inner salt, N-dimethyl-3-sulfo-N-(3-(((3alpha, 1-Propanaminium, 7alpha)-3, rock salt, dTAF[[II]]230, TAF[[II]]250, cholic acid sulfobetaine1-Propanaminium, sales, TAF200, l(3)84Ab, stepk, BG:DS00004.13, TAFII-250, TAF250/230, buffer, Cell, EMILIN4, dTAF230, common salt, TAFII250, Natriumchlorid, p230, 3-(3-cholamidopropyl)dimethylammoniumpropane sulfonate, CHAPS, 3.1.3.48, TAF[[II]]250/230, TFIID, table salt, simple tissue, NaCl, l(2)SH0323, 5beta, Sal, CYH1, N-dimethyl-N-(3-sulfopropyl)-3-(((3alpha, Taf[[II]]250, TAF[[II]]230, Spalt, instrument, Step, CG11628, ionic compound, B130022O04Rik, Striatum-enriched protein-tyrosine phosphatase, Salze, TAF[II]250, natrii chloridum, CG17603, TAF[[II]], DmelCG11628, sal, 7alpha, DmelCG17603, Taf250, STEP, Dietary Sodium, SR3-5, MMRN, TAF230, TAF1"],"additional_accession":[]},"is_claimable":false,"name":"Breast tissue and cancer proteomics","description":"Breast tissue sample from the Koman tissue bank and UW Oncology. Proteomic analysis of non-cancer tissue by BMI catagory.","dates":{"publication":"2025-05-06","submission":"2024-04-15"},"accession":"PXD051458","cross_references":{"TAXONOMY":["NEWT:6945","NEWT:3555","NEWT:241368","NEWT:2","NEWT:157546","NEWT:190802","NEWT:35554","NEWT:9778","NEWT:150475","NEWT:9417","NEWT:347515","NEWT:1216979","NEWT:307972","NEWT:32046","NEWT:544496","NEWT:5180","NEWT:256737","NEWT:2042546","NEWT:115104","NEWT:1081927","NEWT:67825","NEWT:43179","NEWT:13076","NEWT:1249668","NEWT:376741","NEWT:317","NEWT:55153","NEWT:1736309","NEWT:7227","NEWT:7469","NEWT:885318","NEWT:415540","NEWT:4081","NEWT:876138","NEWT:554","NEWT:98334","NEWT:426428","NEWT:237561","NEWT:6928","NEWT:10036","NEWT:7574","NEWT:1351","NEWT:7215","NEWT:272563","NEWT:507601","NCBITaxon:79857","NCBITaxon:6157","NEWT:95648","NEWT:3885","NEWT:746360","NEWT:6239","NEWT:1589","NEWT:470150","NEWT:135622","NEWT:216257","NEWT:6915","NEWT:9986","NEWT:101510","NEWT:4054","NEWT:3880","NEWT:3641","NEWT:8782","NEWT:1263854","NEWT:1000589","NEWT:1902","NEWT:85962","NEWT:160488","NEWT:28104","NEWT:317447","NEWT:7955","NCBITaxon:2","NEWT:985076","NEWT:7959","NEWT:2261","NEWT:4565","NEWT:1264690","NEWT:6192","NEWT:28532","NCBITaxon:38727","NEWT:34305","NEWT:59729","NCBITaxon:183674","NEWT:224308","NEWT:626528","NEWT:139927","NEWT:4558","NEWT:209285","NEWT:216595","NEWT:243230","NEWT:8355","NEWT:1283","NEWT:931281","NEWT:7029","NEWT:1283300","NEWT:6183","NEWT:334747","NEWT:61235","NCBITaxon:79824","NEWT:4787","NCBITaxon:4563","NEWT:5755","NEWT:3218","NEWT:5759","NEWT:1736231","NEWT:436486","NEWT:6287","NEWT:2242","NEWT:300641","NEWT:4784","NEWT:727","NEWT:9796","NEWT:725","NEWT:360106","NEWT:260707","NEWT:287","NEWT:10117","NEWT:10239","NCBITaxon:6191","NEWT:10116","NEWT:1280","NEWT:1836","NEWT:1735272","NEWT:83334","NEWT:185431","NEWT:83332","NEWT:29760","NEWT:260704","NEWT:703612","NEWT:260705","NEWT:80863","NEWT:44685","NEWT:2697049","NEWT:1148","NEWT:11676","NEWT:55571","NEWT:100226","NCBITaxon:6073","NEWT:4530","NEWT:4896","NEWT:6279","NEWT:1123869","NEWT:7370","NEWT:75058","NEWT:83906","NEWT:607699","NEWT:6282","NEWT:208964","NEWT:1134506","NEWT:575584","NEWT:1773","NEWT:38783","NEWT:8727","NEWT:1895","NEWT:1182590","NEWT:8726","NEWT:6669","NEWT:10090","NEWT:935293","NEWT:64152","NEWT:749200","NEWT:4120","NEWT:51515","NEWT:5693","NEWT:8724","NEWT:51511","NEWT:92867","NEWT:8723","NEWT:990346","NEWT:5334","NEWT:145953","NEWT:257309","NEWT:100816","NEWT:230741","NEWT:284812","NCBITaxon:10359","NCBITaxon:1313","NEWT:43330","NEWT:242619","NEWT:44544","NEWT:632957","NEWT:373995","NEWT:5689","NEWT:645463","NEWT:544404","NEWT:3702","NEWT:129249","NEWT:9925","NEWT:8839","NEWT:4232","NEWT:990119","NEWT:2758385","NEWT:4113","NEWT:837","NEWT:11298","NEWT:171101","NEWT:196627","NEWT:408172","NEWT:5691","NEWT:408170","NEWT:493760","NEWT:260710","NEWT:627025","NEWT:400772","NEWT:1097677","NEWT:3708","NEWT:128161","NEWT:106592","NEWT:1117957","NEWT:9913","NEWT:1432138","NEWT:10312","NEWT:1424507","NEWT:4100","NEWT:1076","NEWT:6763","NEWT:803","NEWT:8030","NEWT:29722","NEWT:380394","NEWT:1692259","NEWT:1639","NEWT:188229","NEWT:3818","NEWT:480","NEWT:4909","NEWT:180066","NEWT:67767","NEWT:46835","NEWT:135588","NEWT:1843183","NEWT:95486","NEWT:58002","NEWT:9103","NEWT:4577","NEWT:5664","NEWT:2157","NEWT:146479","NEWT:10306","NEWT:1911079","NEWT:8022","NEWT:145943","NEWT:3635","NEWT:5811","NEWT:235443","NEWT:1480154","NEWT:1274414","NEWT:59202","NEWT:9975","NEWT:3197","NEWT:9615","NEWT:10299","NEWT:860688","NEWT:884019","NEWT:169963","NEWT:36329","NEWT:1147787","NEWT:72407","NEWT:9606","NEWT:367830","NEWT:157295","NEWT:178616","NEWT:410289","NEWT:373153","NEWT:915099","NEWT:74940","NEWT:1450511","NEWT:360094","NEWT:470","NEWT:84023","NEWT:9838","NCBITaxon:9615","NEWT:58334","NEWT:1193501","NEWT:3055","NEWT:6326","NEWT:6689","NEWT:2762","NEWT:5476","NEWT:1174673","NEWT:562","NEWT:33952","NEWT:1274432","NEWT:1274426","NEWT:1423","NEWT:4932","NEWT:70448","NEWT:9825","NEWT:1274423","NEWT:3603","NEWT:698936","NEWT:2759","NEWT:3847","NEWT:39946","NEWT:9823","NEWT:9940","NEWT:327160","NEWT:573","NEWT:9031","NEWT:1274420","NEWT:7091"],"pubmed":["39380725"],"ORCID":["0000-0001-5054-838X"]}}